UK under pressure as BMS sets US-level price for schizophrenia drug

by Aurelia Butler 22 September 2025, 10:45 119 Views

Client Challenge

JavaScript is disabled in your browser.

Please enable JavaScript to proceed.

A required part of this site couldn’t load. This may be due to a browser
extension, network issues, or browser settings. Please check your
connection, disable any ad blockers, or try using a different browser.

FirstFT: Confusion after White House makes changes to work visas

Family offices are still keen on direct deals but retreat from startup, early-stage investing

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

UK under pressure as BMS sets US-level price for schizophrenia drug

FirstFT: Confusion after White House makes changes to work visas

Family offices are still keen on direct deals but retreat from startup, early-stage investing

ITALIAN LANGUAGE

ENGLISH LANGUAGE